Last updated: December 9, 2024
Sponsor: Children's Hospital Medical Center, Cincinnati
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05277272
2021-0821
Sobi.HLH-RWE102
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with clinically suspected or confirmed HLH, including those meeting theHLH-2004 diagnostic criteria (primary or secondary forms, including malignancy) andother forms of HLH (macrophage activation syndrome [MAS], cytokine release syndrome [CRS], etc.)
Signed and dated informed consent and assent (adolescents)
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 200
Study Start date:
December 31, 2021
Estimated Completion Date:
January 31, 2026
Study Description
Connect with a study center
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.